Skip to content
mapperlab
← Dashboard
Stock

NGVT

INGEVITY CORPORATION
MaterialsSpecialty ChemicalsLatest close $676 of 27 marquee funds currently hold1 CUSIP mapped
Current holders
6
27 funds tracked
Ever held
8
Current + past
New this quarter
1
Exited this quarter
1

Marquee-fund ownership over time

Feb 16, 2021Nov 15, 2021Nov 13, 2024May 15, 2026
Now
6

This quarter's activity

Current holders

Sorted by tenure (longest first)
FundEntry priceLatest closeReturn on entry
Bridgewater Associates re-entered$38$67+77%
Citadel Advisors$35$67+90%
AQR Capital Management$35$67+90%
Millennium Management$35$67+90%
Renaissance Technologies$43$67+54%
Point72 Asset Management$68$67-2%

“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.

Past holders

Funds that exited at some point
FundEntry → ExitReturn
D.E. Shaw→ $68+93%
Maverick Capital 2× in & out→ $83+0%

Insider activity

Form 4 — officers, directors, 10%+ owners

Filed within two business days of each transaction by anyone with material insider status at Ingevity Corp. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.

Filings · last 30d
2
Filings · last 90d
23
Total on file
320
Recent SEC buffer
Most recent
Jun 1, 2026

30d / 90d windows measured from Jun 1, 2026 — the most recent Form 4 on file — not from today.

Showing 15 of 320 recent Form 4 filings. Browse all on EDGAR ↗

Fundamentals

XBRL · INGEVITY CORPORATION

Annual figures sourced directly from INGEVITY CORPORATION's 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.

Revenue
$1.17B
FY2025-3% YoY
Net income
-$167.1M
FY2025+61% YoY
EPS (diluted)
$-4.61
FY2025+61% YoY
Free cash flow(?)
$331.2M
FY2025+158% YoY

Recent SEC filings

10-K · 10-Q · 8-K · 13D/G · proxy

The most recent material filings for Ingevity Corp — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.

Trade history

Every open→close lifecycle across tracked funds
FundOpen dateClose dateOpen priceClose price / currentReturn
Point72 Asset ManagementQ2 2026open$68$67-2%
Bridgewater AssociatesQ4 2025open$51$67+33%
Renaissance TechnologiesQ2 2025open$43$67+54%
Bridgewater AssociatesQ3 2024Q4 2024$35$46+30%
Citadel AdvisorsQ3 2024open$35$67+90%
D.E. ShawQ3 2024Q2 2026$35$68+93%
AQR Capital ManagementQ3 2024open$35$67+90%
Millennium ManagementQ3 2024open$35$67+90%
Bridgewater AssociatesQ4 2023Q2 2024$38$55+47%
Maverick CapitalQ3 2021Q4 2021$83$83+0%
Maverick CapitalQ1 2021Q2 2021$69$89+29%
Caveats
  • Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
  • Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
  • “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
  • Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
  • Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.